RNS Number : 1734R
Worldpay, Inc
27 February 2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
FOR IMMEDIATE RELEASE
February 27, 2019
Worldpay, Inc.
Filing of Annual Report on Form 10-K for the Year Ended December 31, 2018
Worldpay, Inc. (the "Company") has submitted its Annual Report on Form 10-K for the year ended December 31, 2018 to the National Storage Mechanism. The Company's Form 10-K will be available for viewing shortly for inspection at: http://www.morningstar.co.uk/uk/NSM.
Pursuant to its obligations under the U.S. Securities Exchange Act of 1934, as amended, the Company filed its Annual Report on Form 10-K on February 26, 2019. A copy of the Company's Form 10-K is available on the SEC's website at http://www.sec.gov.
Enquiries
Worldpay, Inc.
Nathan Rozof, Investor Relations
Andrew Ciafardini, Corporate Communications
|
+1 513 900 4811
+1 513 900 5308
|
Goldman Sachs International (U.K. Corporate Broker to Worldpay, Inc.)
Charlie Lytle
Tom Hartley
Adam Laikin
Smithfield (PR adviser to Worldpay, Inc.)
John Kiely
|
+44 (0) 207 774 1000
+44 (0) 203 047 2538
|
Worldpay, Inc. LEI number: 213800TV56O7TZI4U902
About Worldpay, Inc.
Worldpay, Inc. (NYSE: WP; LSE: WPY) is a leading payments technology company with unique capability to power global omni-commerce. With an integrated technology platform, Worldpay offers a comprehensive suite of products and services, delivered globally through a single provider. Worldpay processes over 40 billion transactions annually, supporting more than 300 payment types across 146 countries and 126 currencies. The company is focused on expanding into high-growth markets and customer segments, including global eCommerce, integrated payments and B2B. Visit us at www.worldpay.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the
Financial Conduct Authority to act as a Primary Information Provider in the
United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com or visit
www.rns.com.
END
MSCTFMJTMBMTBBL